Loading...
LifeMD Inc (LFMD) is not a strong buy for a beginner, long-term investor at this moment. While the company shows revenue growth, its declining net income, EPS, and gross margin, coupled with neutral trading sentiment and no significant positive catalysts, make it a stock to hold for now. The technical indicators also suggest a lack of clear bullish momentum.
The MACD is slightly positive and expanding, indicating minor bullish momentum. However, the RSI is neutral at 43.224, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support and resistance levels are Pivot: 2.808, R1: 3.003, S1: 2.614, R2: 3.124, S2: 2.493, suggesting the stock is trading near its support levels but lacks a strong upward trend.

The company's revenue increased by 12.95% YoY in Q3 2025, which indicates growth in its core business.
Net income dropped by 15.67% YoY, EPS declined by 23.08% YoY, and gross margin fell by 3.20% YoY. There are no significant trading trends from hedge funds or insiders, no recent news, and no recent congress trading data to indicate strong interest in the stock.
In Q3 2025, revenue increased to $60.17M (up 12.95% YoY), but net income dropped to -$4.58M (down 15.67% YoY). EPS fell to -0.1 (down 23.08% YoY), and gross margin decreased to 87.69% (down 3.20% YoY).
No data available for analyst ratings or price target changes.